US Stock MarketDetailed Quotes

PTPI Petros Pharmaceuticals

Watchlist
  • 0.2944
  • -0.0177-5.67%
Close Dec 20 16:00 ET
  • 0.2600
  • -0.0344-11.68%
Post 20:01 ET
2.95MMarket Cap-0.08P/E (TTM)

Petros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
80.94%-771.25K
-190.59%-1.66M
-51.64%-1.13M
40.41%-7.63M
-43.91%-2.26M
-131.02%-4.05M
86.38%-572.07K
85.81%-748.36K
-7.88%-12.8M
81.09%-1.57M
Net income from continuing operations
51.19%-2.22M
74.00%-662.03K
-56.13%-2.16M
59.26%-8.16M
107.54%318.15K
67.10%-4.55M
-40.56%-2.55M
-695.04%-1.39M
-122.97%-20.04M
48.43%-4.22M
Operating gains losses
---202K
---1.61M
---1.73M
-3,154.13%-14.97M
---5.26M
----
----
----
95.12%-460K
--0
Depreciation and amortization
-10.70%768.26K
-12.18%754.67K
-12.21%753.53K
-40.25%3.42M
-18.99%837.17K
-44.88%860.34K
-44.95%859.33K
-45.01%858.35K
-16.89%5.72M
-38.91%1.03M
Other non cash items
----
----
----
443.67%10.92M
-340.39%-164.13K
----
----
----
-1,801.58%-3.18M
151.58%68.28K
Change In working capital
146.03%824.28K
-125.05%-278.79K
500.40%1.76M
123.90%789.05K
36.89%1.91M
-164.39%-1.79M
124.95%1.11M
85.45%-438.61K
-87.20%-3.3M
165.11%1.39M
-Change in receivables
49.80%-214.01K
206.42%154.71K
198.36%320.27K
-127.94%-144.13K
-55.44%753.16K
-121.19%-426.31K
92.79%-145.37K
72.17%-325.61K
-79.76%515.96K
392.96%1.69M
-Change in inventory
173.21%70.62K
45.56%128.62K
173.62%40.56K
132.76%273.61K
-57.06%336.8K
60.68%-96.46K
68.40%88.36K
96.14%-55.09K
-302.38%-835.32K
1,424.19%784.38K
-Change in prepaid assets
840.64%305.71K
215.78%463.42K
-16.14%151.16K
-158.72%-967.87K
-880.87%-1.33M
-92.26%32.5K
-82.12%146.76K
-24.11%180.24K
328.86%1.65M
121.25%169.99K
-Change in payables and accrued expense
150.49%675.66K
-191.19%-998.57K
5,202.22%1.39M
135.84%1.63M
264.24%1.85M
-304.46%-1.34M
133.18%1.1M
103.35%26.21K
-20.54%-4.55M
-187.88%-1.13M
-Change in other current liabilities
-323.55%-84.04K
46.91%-26.95K
-612.39%-28.45K
93.72%-4.83K
109.76%12.34K
163.57%37.59K
-162.30%-50.77K
-103.12%-3.99K
66.12%-76.97K
69.99%-126.48K
-Change in other working capital
--70.34K
--0
54.97%-117.24K
----
----
--0
---21.01K
---260.36K
----
----
Cash from discontinued investing activities
Operating cash flow
80.94%-771.25K
-190.59%-1.66M
-51.64%-1.13M
40.41%-7.63M
-43.91%-2.26M
-131.02%-4.05M
86.38%-572.07K
85.81%-748.36K
-7.88%-12.8M
81.09%-1.57M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-118.97%-2.77M
-439.19%-1.96M
-213.39%-1.12M
810.43%11.54M
-1,182.34%-2.37M
4,142.36%14.63M
-105.23%-363.2K
60.24%-357.83K
-108.75%-1.62M
-100.77%-185.06K
Net issuance payments of debt
-4.57%-385.49K
-4.57%-379.79K
--0
9.86%-1.46M
-102.20%-374.18K
-1.85%-368.65K
-105.23%-363.2K
60.24%-357.83K
77.41%-1.62M
89.37%-185.06K
Net preferred stock issuance
---2.39M
---1.58M
---1.12M
---2M
---2M
--0
--0
--0
--0
----
Net other financing activities
----
----
----
--15M
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-118.97%-2.77M
-439.19%-1.96M
-213.39%-1.12M
810.43%11.54M
-1,182.34%-2.37M
4,142.36%14.63M
-105.23%-363.2K
60.24%-357.83K
-108.75%-1.62M
-100.77%-185.06K
Net cash flow
Beginning cash position
1.02%7.46M
33.18%11.08M
41.49%13.34M
-60.47%9.43M
60.71%17.97M
-44.45%7.38M
-52.92%8.32M
-60.47%9.43M
39.14%23.85M
37.45%11.18M
Current changes in cash
-133.68%-3.57M
-287.13%-3.62M
-103.97%-2.26M
127.12%3.91M
-163.93%-4.63M
600.85%10.59M
78.63%-935.27K
82.09%-1.11M
-314.99%-14.42M
-111.17%-1.76M
End cash Position
-78.33%3.89M
1.02%7.46M
33.18%11.08M
41.49%13.34M
41.49%13.34M
60.71%17.97M
-44.45%7.38M
-52.92%8.32M
-60.47%9.43M
-60.47%9.43M
Free cash flow
80.47%-790.38K
-190.59%-1.66M
-51.64%-1.13M
40.41%-7.63M
-43.91%-2.26M
-131.02%-4.05M
86.38%-572.07K
85.81%-748.36K
-7.88%-12.8M
81.09%-1.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 80.94%-771.25K-190.59%-1.66M-51.64%-1.13M40.41%-7.63M-43.91%-2.26M-131.02%-4.05M86.38%-572.07K85.81%-748.36K-7.88%-12.8M81.09%-1.57M
Net income from continuing operations 51.19%-2.22M74.00%-662.03K-56.13%-2.16M59.26%-8.16M107.54%318.15K67.10%-4.55M-40.56%-2.55M-695.04%-1.39M-122.97%-20.04M48.43%-4.22M
Operating gains losses ---202K---1.61M---1.73M-3,154.13%-14.97M---5.26M------------95.12%-460K--0
Depreciation and amortization -10.70%768.26K-12.18%754.67K-12.21%753.53K-40.25%3.42M-18.99%837.17K-44.88%860.34K-44.95%859.33K-45.01%858.35K-16.89%5.72M-38.91%1.03M
Other non cash items ------------443.67%10.92M-340.39%-164.13K-------------1,801.58%-3.18M151.58%68.28K
Change In working capital 146.03%824.28K-125.05%-278.79K500.40%1.76M123.90%789.05K36.89%1.91M-164.39%-1.79M124.95%1.11M85.45%-438.61K-87.20%-3.3M165.11%1.39M
-Change in receivables 49.80%-214.01K206.42%154.71K198.36%320.27K-127.94%-144.13K-55.44%753.16K-121.19%-426.31K92.79%-145.37K72.17%-325.61K-79.76%515.96K392.96%1.69M
-Change in inventory 173.21%70.62K45.56%128.62K173.62%40.56K132.76%273.61K-57.06%336.8K60.68%-96.46K68.40%88.36K96.14%-55.09K-302.38%-835.32K1,424.19%784.38K
-Change in prepaid assets 840.64%305.71K215.78%463.42K-16.14%151.16K-158.72%-967.87K-880.87%-1.33M-92.26%32.5K-82.12%146.76K-24.11%180.24K328.86%1.65M121.25%169.99K
-Change in payables and accrued expense 150.49%675.66K-191.19%-998.57K5,202.22%1.39M135.84%1.63M264.24%1.85M-304.46%-1.34M133.18%1.1M103.35%26.21K-20.54%-4.55M-187.88%-1.13M
-Change in other current liabilities -323.55%-84.04K46.91%-26.95K-612.39%-28.45K93.72%-4.83K109.76%12.34K163.57%37.59K-162.30%-50.77K-103.12%-3.99K66.12%-76.97K69.99%-126.48K
-Change in other working capital --70.34K--054.97%-117.24K----------0---21.01K---260.36K--------
Cash from discontinued investing activities
Operating cash flow 80.94%-771.25K-190.59%-1.66M-51.64%-1.13M40.41%-7.63M-43.91%-2.26M-131.02%-4.05M86.38%-572.07K85.81%-748.36K-7.88%-12.8M81.09%-1.57M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -118.97%-2.77M-439.19%-1.96M-213.39%-1.12M810.43%11.54M-1,182.34%-2.37M4,142.36%14.63M-105.23%-363.2K60.24%-357.83K-108.75%-1.62M-100.77%-185.06K
Net issuance payments of debt -4.57%-385.49K-4.57%-379.79K--09.86%-1.46M-102.20%-374.18K-1.85%-368.65K-105.23%-363.2K60.24%-357.83K77.41%-1.62M89.37%-185.06K
Net preferred stock issuance ---2.39M---1.58M---1.12M---2M---2M--0--0--0--0----
Net other financing activities --------------15M------------------------
Cash from discontinued financing activities
Financing cash flow -118.97%-2.77M-439.19%-1.96M-213.39%-1.12M810.43%11.54M-1,182.34%-2.37M4,142.36%14.63M-105.23%-363.2K60.24%-357.83K-108.75%-1.62M-100.77%-185.06K
Net cash flow
Beginning cash position 1.02%7.46M33.18%11.08M41.49%13.34M-60.47%9.43M60.71%17.97M-44.45%7.38M-52.92%8.32M-60.47%9.43M39.14%23.85M37.45%11.18M
Current changes in cash -133.68%-3.57M-287.13%-3.62M-103.97%-2.26M127.12%3.91M-163.93%-4.63M600.85%10.59M78.63%-935.27K82.09%-1.11M-314.99%-14.42M-111.17%-1.76M
End cash Position -78.33%3.89M1.02%7.46M33.18%11.08M41.49%13.34M41.49%13.34M60.71%17.97M-44.45%7.38M-52.92%8.32M-60.47%9.43M-60.47%9.43M
Free cash flow 80.47%-790.38K-190.59%-1.66M-51.64%-1.13M40.41%-7.63M-43.91%-2.26M-131.02%-4.05M86.38%-572.07K85.81%-748.36K-7.88%-12.8M81.09%-1.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data